New ulcerative colitis drug enters first human safety tests
Knowledge-focused
Recruiting now
This early-stage study is testing a new drug, TL-003, to see if it is safe and how the body processes it. The study first involves healthy adults, then a small group of people with ulcerative colitis. The main goal is to check for side effects and measure drug levels in the blood…
Phase: PHASE1 • Sponsor: TrueLab Biopharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC